FTC Halts Bogus Cancer Cures

The Federal Trade Commission has brought to a halt two peddlers of bogus cancer cures that were targeted during Operation…

15 years ago

FTC Offers Red Flags Web Site To Help Creditors and Financial Institutions Design Identity Theft Prevention Programs

The Federal Trade Commission has launched a Web site to help entities covered by the Red Flags Rule design and…

15 years ago

FTC Offers Red Flags Web Site To Help Creditors and Financial Institutions Design Identity Theft Prevention Programs

The Federal Trade Commission has launched a Web site to help entities covered by the Red Flags Rule design and…

15 years ago

FTC Intervenes in BASFs Proposed $5.1 Billion Acquisition of Ciba Holding Inc.

BASF has settled Federal Trade Commission charges that its proposed $5.1 billion acquisition of rival chemical manufacturer Ciba Holding Inc.…

15 years ago

FTC Intervenes in BASFs Proposed $5.1 Billion Acquisition of Ciba Holding Inc.

BASF has settled Federal Trade Commission charges that its proposed $5.1 billion acquisition of rival chemical manufacturer Ciba Holding Inc.…

15 years ago

Telemarketers Settle Charges of Misleading Consumers with Free Product Pitches

A group of sellers and telemarketers charged in 2008’s “Operation Tele-PHONEY” interagency law enforcement sweep have agreed to post a…

15 years ago

Telemarketers Settle Charges of Misleading Consumers with Free Product Pitches

A group of sellers and telemarketers charged in 2008’s “Operation Tele-PHONEY” interagency law enforcement sweep have agreed to post a…

15 years ago

Competition Acting Director David Wales to Leave FTC

Federal Trade Commission Chairman Jon Leibowitz announced today that David P. Wales, Acting Director of the Bureau of Competition for…

15 years ago

Competition Acting Director David Wales to Leave FTC

Federal Trade Commission Chairman Jon Leibowitz announced today that David P. Wales, Acting Director of the Bureau of Competition for…

15 years ago

Bristol-Myers Squibb to Pay $2.1 Million Penalty for Failure to Disclose Agreement Involving Substantial Payments to Delay Entry of a Generic Version of the Drug Plavix

Drug maker Bristol-Myers Squibb Company (BMS) will pay $2.1 million – the largest fine allowed by law – for failing…

15 years ago